Does CABOZANTINIB S-MALATE Cause Pleural effusion? 272 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 272 reports of Pleural effusion have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.7% of all adverse event reports for CABOZANTINIB S-MALATE.
272
Reports of Pleural effusion with CABOZANTINIB S-MALATE
0.7%
of all CABOZANTINIB S-MALATE reports
69
Deaths
163
Hospitalizations
How Dangerous Is Pleural effusion From CABOZANTINIB S-MALATE?
Of the 272 reports, 69 (25.4%) resulted in death, 163 (59.9%) required hospitalization, and 16 (5.9%) were considered life-threatening.
Is Pleural effusion Listed in the Official Label?
Yes, Pleural effusion is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Pleural effusion Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE